Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma is a research paper published in Immunity (2025). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: 1R37CA279822-01
Yale Cancer Center
Grant: P30CA016359
U.S. Department of Defense
Grant: KC190128/W81XWH-20-1-0882
U.S. Department of Defense
Grant: KC220016/HT9425-23-1-0735
National Institutes of Health
Grant: R01CA278980
National Institutes of Health
Grant: U2CCA233195
National Institutes of Health
Grant: R50CA265182
NCI NIH HHS
Grant: P30 CA006516
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P50 CA101942
NCI NIH HHS
Grant: R37 CA279822
Novartis
Novartis Pharmaceuticals Corporation
FWCI
7.09
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords